About

Bausch Health was previously known as Valeant Pharmaceuticals, and as well as this recent rebranding the company continues to provide services that develop, manufacture and market a broad range of pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology, and branded generics. Headquartered in the Canadian province of Québec, a huge contributor to the company’s US$8.72bn 2017 revenue figure is the company’s EMEA operation, which is extensive and spans a number of product areas and therapeutic focuses. Bausch Health’s presence in the Central and Eastern Europe region is through outposts in Poland, Russia and the CIS, and the legal director the EMEA region, Nemanja Martinovic, presides over a multijurisdictional remit from his base in Belgrade. Martinovic works in conjunction with a number of legal counsels to assist the specialist pharmaceutical multinational’s legal risk mitigation and all relevant compliance issues. The team is well-known for its agile and flexible response to a constantly changing and rigidly regulated pharmaceutical market sector in many different countries.